CSIMarket
 


Lemaitre Vascular Inc   (LMAT)
Other Ticker:  
 
 

LMAT's Net Income Growth by Quarter and Year

Lemaitre Vascular Inc 's Net Income results by quarter and year




LMAT Net Income (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December 8.47 5.63 6.18 7.03
III Quarter September 7.50 5.46 6.50 7.51
II Quarter June 8.10 3.52 8.30 3.50
I Quarter March 6.04 6.04 5.93 3.17
FY   30.11 20.65 26.91 21.21



LMAT Net Income fourth quarter 2023 Y/Y Growth Comment
Lemaitre Vascular Inc achieved in the fourth quarter 2023, above Company average Net Income rise of 50.36% year on year, to $ 8.47 millions.

Looking into fourth quarter 2023 results within Medical Equipment & Supplies industry 22 other companies have achieved higher Net Income growth. While Lemaitre Vascular Inc ' s Net Income jump of 50.36% ranks overall at the positon no. 689 in the fourth quarter 2023.




LMAT Net Income ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December 50.36 % -8.9 % -12.09 % 52.49 %
III Quarter September 37.36 % -16 % -13.45 % 44.98 %
II Quarter June 130.11 % -57.59 % 137.14 % -24.24 %
I Quarter March 0 % 1.85 % 87.07 % -9.69 %
FY   45.79 % -23.26 % 26.87 % 18.36 %

Financial Statements
Lemaitre Vascular Inc 's fourth quarter 2023 Net Income $ 8.47 millions LMAT's Income Statement
Lemaitre Vascular Inc 's fourth quarter 2022 Net Income $ 5.63 millions Quarterly LMAT's Income Statement
New: More LMAT's historic Net Income Growth >>


LMAT Net Income (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December 12.87 % 3.11 % -4.92 % -6.39 %
III Quarter September -7.41 % 55.11 % -21.69 % 114.57 %
II Quarter June 34.11 % -41.72 % 39.97 % 10.41 %
I Quarter March 7.28 % -2.27 % -15.65 % -31.24 %
FY (Year on Year)   45.79 % -23.26 % 26.87 % 18.36 %




Net Income fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #23
Healthcare Sector #57
Overall #689

Net Income Y/Y Growth Statistics
High Average Low
160.26 % 30.83 % -29.1 %
(Sep. 30, 2015)   (March 31, 2014)
Net Income fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #23
Healthcare Sector #57
Overall #689
Net Income Y/Y Growth Statistics
High Average Low
160.26 % 30.83 % -29.1 %
(Sep. 30, 2015)   (March 31, 2014)

Net Income by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Lemaitre Vascular Inc 's Q/Q Net Income Growth


Net Income Q/Q Growth Statistics
High Average Low
127.12 % 12.08 % -50.7 %
(Jun 30 2018)  


LMAT's IV. Quarter Q/Q Net Income Comment
Lemaitre Vascular Inc achieved in the IV. Quarter 2023 above company average sequential Net Income rise of 12.87%, to $ 8.47 millions, from $7.50 millions in the third quarter.
Lemaitre Vascular Inc is going from strength to strength, with claiming better then regular gain, and also increasing rate, Sandra Teixeira, a business consultant allocated in Porto mentioned.

Within Medical Equipment & Supplies industry 20 other companies have achieved higher Net Income quarter on quarter growth. While Lemaitre Vascular Inc 's Net Income growth quarter on quarter, overall rank is 442.


Net Income Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #21
Healthcare Sector #37
Overall #442
Net Income Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #21
Healthcare Sector #37
Overall #442
Net Income Q/Q Growth Statistics
High Average Low
127.12 % 12.08 % -50.7 %
(Jun 30 2018)  


LMAT's IV. Quarter Q/Q Net Income Comment
Lemaitre Vascular Inc achieved in the IV. Quarter 2023 above company average sequential Net Income rise of 12.87%, to $ 8.47 millions, from $7.50 millions in the third quarter.
Lemaitre Vascular Inc is undergoing a remarkable growth, not only claiming higher then normal growth, and additionally improving rate.

Within Medical Equipment & Supplies industry 20 other companies have achieved higher Net Income quarter on quarter growth. While Lemaitre Vascular Inc 's Net Income growth quarter on quarter, overall rank is 442.


Lemaitre Vascular Inc 's 12 Months Net Income Growth Year on Year


Net Income TTM Growth

12 Months Ending
(Dec 31 2023)
12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
Cumulative Net Income 12 Months Ending $ 30.11 $ 27.27 $ 25.22 $ 20.64 $ 20.64
Y / Y Net Income Growth (TTM) 45.89 % 28.72 % 13.44 % -23.61 % -23.31 %
Year on Year Net Income Growth Overall Ranking # 893 # 893 # 1458 # 796 # 490
Seqeuential Net Income Change (TTM) 10.41 % 8.11 % 22.21 % 0.01 % -2.59 %
Seq. Net Income Growth (TTM) Overall Ranking # 689 # 1001 # 1390 # 1083 # 922




Cumulative Net Income growth Comment
Lemaitre Vascular Inc saw improvement in Net Income growth trend, posting cumulative 12 months Net Income growth of 45.89% year on year, to $ 30 millions if the fiscal year would have ended in Dec 31 2023.
Lemaitre Vascular Inc 's trailing twelve months Net Income growth was higher than company's average 30.83% and higher than 28.72% growth in Sep 30 2023.
But sequential rise was less at 10.41 % from $27.27 millions recorded in the period from Sep 30 2023 to Dec 31 2022 Sandra Teixeira continued.
We witness drop-off developing, more obvious if you pay attention to the average sequential Net Income rise what is higher at 30.83%.
The growth was even stronger from twelve months ended Sep 30 2023 clinched at 10.41 % jump from $27.27 millions in twelve months ending a quarter Sep 30 2023.

In the Healthcare sector 69 other companies have achieved higher trailing twelve month Net Income growth. While overall Net Income growth ranking, remained unchanged compare to the previous quarter at no. 893.

Net Income TTM Q/Q Growth Statistics
High Average Low
160.26 %
30.83 %
-29.1 %
 

Net Income TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 23
Healthcare Sector # 70
Overall # 893

Net Income TTM Y/Y Growth Statistics
High Average Low
160.26 %
30.83 %
-29.1 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 23
Sector # 57
S&P 500 # 689
Cumulative Net Income growth Comment
Lemaitre Vascular Inc saw improvement in Net Income growth trend, posting cumulative 12 months Net Income growth of 45.89% year on year, to $ 30 millions if the fiscal year would have ended in Dec 31 2023.
Lemaitre Vascular Inc 's trailing twelve months Net Income growth was higher than company's average 30.83% and higher than 28.72% growth in Sep 30 2023.
But from twelve months ended Sep 30 2023 growth rate was beneth at 10.41 % from $27.27 millions recorded in twelve months ending a quarter Sep 30 2023.
There is drop-off happening, more evident if you pay attention to the usual Q/Q TTM historic increase which is higher at 30.83% Sandra Teixeira noted.
The growth was much stronger from twelve months ended Sep 30 2023 exhibited at 10.41 % rise from $27.27 millions in the period from Sep 30 2023 to Dec 31 2022.

In the Healthcare sector 69 other companies have achieved higher trailing twelve month Net Income growth. While overall Net Income growth ranking, remained unchanged compare to the previous quarter at no. 893.

Net Income TTM Q/Q Growth Statistics
High Average Low
160.26 %
30.83 %
-29.1 %
 


Net Income TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 23
Healthcare Sector # 70
Overall # 893

Net Income TTM Y/Y Growth Statistics
High Average Low
160.26 %
30.83 %
-29.1 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 23
Sector # 57
S&P 500 # 689




Other Net Income Growth
Medical Equipment & Supplies Industry Net Income Growth Trends and Statistics
Healthcare Sector Net Income Growth Statistics
Net Income Growth Trends for overall market
LMAT's Net Income Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Net Income Growth
Lowest Ranking Net Income Growth
Net Income Growth for LMAT's Competitors
Net Income Growth for Lemaitre Vascular Inc 's Suppliers
Net Income Growth for LMAT's Customers

You may also want to know
LMAT's Annual Growth Rates LMAT's Profitability Ratios LMAT's Asset Turnover Ratio LMAT's Dividend Growth
LMAT's Roe LMAT's Valuation Ratios LMAT's Financial Strength Ratios LMAT's Dividend Payout Ratio
LMAT's Roa LMAT's Inventory Turnover Ratio LMAT's Growth Rates LMAT's Dividend Comparisons



Companies with similar Net Income rise for the quarter ending Dec 31 2023 within Healthcare SectorY/Y Change %Net Income for the quarter ending Dec 31 2023
Davita Inc 82.10%$ 82.105 millions
Intuitive Surgical Inc 81.38%$ 81.378 millions
Astrazeneca Plc81.02%$ 81.020 millions
Tactile Systems Technology Inc 77.49%$ 77.494 millions
Quest Diagnostics Inc76.72%$ 76.724 millions
Dr Reddy s Laboratories Limited76.21%$ 76.206 millions
3m Company74.40%$ 74.401 millions
Electromed Inc 71.34%$ 71.341 millions
Tenet Healthcare Corp66.42%$ 66.423 millions
Alpha Pro Tech Ltd 66.36%$ 66.364 millions
Neurocrine Biosciences Inc 65.96%$ 65.955 millions
Cytek Biosciences Inc 64.76%$ 64.760 millions
United Therapeutics Corporation64.35%$ 64.345 millions
Fonar Corporation64.30%$ 64.296 millions
Select Medical Holdings Corp63.87%$ 63.868 millions
Abbott Laboratories54.31%$ 54.308 millions
Lemaitre Vascular Inc 50.44%$ 50.435 millions
Msa Safety Incorporated48.40%$ 48.401 millions
Halozyme Therapeutics Inc 47.98%$ 47.981 millions
Integer Holdings Corporation45.48%$ 45.482 millions
Cadre Holdings Inc 45.39%$ 45.386 millions
Chemed Corporation44.95%$ 44.952 millions
Viemed Healthcare Inc 42.62%$ 42.617 millions
Healthcare Services Group Inc 39.85%$ 39.848 millions
Ufp Technologies Inc 37.18%$ 37.178 millions
Catalyst Pharmaceuticals Inc 36.80%$ 36.799 millions
National Research Corporation33.38%$ 33.384 millions
West Pharmaceutical Services Inc 33.01%$ 33.010 millions
Baxter International Inc 32.97%$ 32.973 millions
Hologic Inc31.54%$ 31.537 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com